This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2040 Remove Conditions Remove Epilepsy Related Topics
Chronic Pain Clinical Trials Data Compliance Consumption Safety Treatment Policy Access Cultivation More Related Topics >
article thumbnail

MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation

Cannabis Law Report

OCTOBER 26, 2021

Studies estimate that the number of people suffering from rheumatoid arthritis may rise to over 78 million by 2040. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52
Pharmaceutical Clinical Trials Research and Development Therapy 52
article thumbnail

Euro & UK Roundup: Czech Republic, Ireland, San Marino, UK

Cannabis Law Report

SEPTEMBER 28, 2019

Legislation passed last July allows a Consultant doctor to prescribe medicinal cannabis, but it is restricted to just three conditions. 24 people in Ireland are now being prescribed medicinal cannabis, but it only includes those suffering from multiple sclerosis, epilepsy and post chemotherapy sickness. San Marino.

Epilepsy 40
Epilepsy Chronic Pain Medicine Pharmaceutical 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024